<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39359780</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2049-0801</ISSN><JournalIssue CitedMedium="Print"><Volume>86</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of medicine and surgery (2012)</Title><ISOAbbreviation>Ann Med Surg (Lond)</ISOAbbreviation></Journal><ArticleTitle>Unveiling post-COVID-19 Rasmussen's encephalitis: a case report of rare neurological complication.</ArticleTitle><Pagination><StartPage>6330</StartPage><EndPage>6334</EndPage><MedlinePgn>6330-6334</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MS9.0000000000002569</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND IMPORTANCE" NlmCategory="UNASSIGNED">Rasmussen encephalitis (RE) is a rare autoimmune disorder that causes unilateral inflammation of the cerebral cortex and can lead to drug-resistant epilepsy and progressive neurological decline. Although the emergence of RE following COVID-19 has not been well documented, it emphasizes the need to understand the impact of COVID-19 on neurological health. This case emphasizes the importance of early recognition and intervention to prevent adverse outcomes related to post-COVID-19 neurological complications.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="UNASSIGNED">A 30-year-old woman, recently diagnosed with COVID-19, experienced recurrent seizures that primarily affected the left side of her body. Despite medical management, signs of progressive weakness and altered consciousness were observed. Neurological examination, imaging, and electroencephalography confirmed a diagnosis of post-COVID-19 RE. Despite conservative management, the patient's condition continued to deteriorate, ultimately resulting in fatal outcomes.</AbstractText><AbstractText Label="CLINICAL DISCUSSION" NlmCategory="UNASSIGNED">The relationship between COVID-19 and autoimmune responses, which can lead to neurological complications, such as RE, is a matter of concern. Accurate diagnosis of RE depends on imaging and EEG studies; however, a definitive diagnosis often requires histopathological examination. The management of RE involves the use of anti-seizure medications and surgical interventions to control symptoms and improve outcomes. However, the unusual presentation of this case, along with challenges in diagnosis and treatment, underscores the need for increased awareness and extensive research on the neurological consequences of COVID-19.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This case underscores the severe neurological consequences that can emerge after COVID-19, emphasizing the need for prompt identification and intervention. Additional research is essential to improve the comprehension and management of the neurological aftermath of COVID-19 with the ultimate goal of enhancing patient outcomes.</AbstractText><CopyrightInformation>Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Naisr</LastName><ForeName>Zaira</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0009-0008-4983-6999</Identifier><AffiliationInfo><Affiliation>Rawalpindi Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Abdullah Munir</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>King Edward Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arooj</LastName><ForeName>Hajira</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Rawalpindi Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Lava</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8258-2977</Identifier><AffiliationInfo><Affiliation>Private practice at Dr. Lava Abdullah Clinic, Damascus, Syrian Arab Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naeem</LastName><ForeName>Zunaira</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Allama Iqbal Medical College, Lahore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashmi</LastName><ForeName>Muhammad Usman</ForeName><Initials>MU</Initials><Identifier Source="ORCID">0000-0002-7581-125X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Rawalpindi Medical University, Rawalpindi.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rahmah Academy of Research Excellence, Islamabad, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Med Surg (Lond)</MedlineTA><NlmUniqueID>101616869</NlmUniqueID><ISSNLinking>2049-0801</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 complications</Keyword><Keyword MajorTopicYN="N">Rasmussen</Keyword><Keyword MajorTopicYN="N">autoimmune diseases</Keyword><Keyword MajorTopicYN="N">case reports</Keyword><Keyword MajorTopicYN="N">central nervous system</Keyword><Keyword MajorTopicYN="N">encephalitis</Keyword><Keyword MajorTopicYN="N">refractory</Keyword><Keyword MajorTopicYN="N">seizures</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39359780</ArticleId><ArticleId IdType="pmc">PMC11444579</ArticleId><ArticleId IdType="doi">10.1097/MS9.0000000000002569</ArticleId><ArticleId IdType="pii">AMSU-D-24-00948</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hammed A, Badour M, Baqla S, et al. . Diagnosis and treatment of Rasmussen’s encephalitis pose a big challenge: two case reports and literature review. Ann Med Surg 2021;68:1–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8358639</ArticleId><ArticleId IdType="pubmed">34401124</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagarde S, Boucraut J, Bartolomei F. Medical treatment of Rasmussen’s encephalitis: a systematic review. Rev Neurol 2022;178:675–691.</Citation><ArticleIdList><ArticleId IdType="pubmed">35131107</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadkar S, Bien CG, Kruse CA, et al. . Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol 2014;13:195–205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4005780</ArticleId><ArticleId IdType="pubmed">24457189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ai J, Wang Y, Liu D, et al. . Genetic factors in Rasmussen’s encephalitis characterized by whole-exome sequencing. Front Neurosci 2021;15:1–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8523672</ArticleId><ArticleId IdType="pubmed">34675770</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Zhang J, Liu Q, et al. . Neurological risks of COVID-19 in women: the complex immunology underpinning sex differences. Front Immunol 2023;14:1281310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685449</ArticleId><ArticleId IdType="pubmed">38035090</ArticleId></ArticleIdList></Reference><Reference><Citation>Melzer N, Rosenow F. Autoimmune-associated epilepsy—a challenging concept. Seizure Eur J Epilepsy 2024:S1059–1311(24)00156-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">38852019</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhary P, Shafaati M, Abu Salah MAH, et al. . Zoonotic diseases in a changing climate scenario: Revisiting the interplay between environmental variables and infectious disease dynamics. Travel Med Infect Dis 2024;58:1–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">38336336</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunziata F, Vassallo E, Alessio M, et al. . COVID-19-associated severe mono-hemispheric encephalitis in a young infant. Neurol Sci 2022;43:4645–4648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9038513</ArticleId><ArticleId IdType="pubmed">35471743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bien CG. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005;128:454–471.</Citation><ArticleIdList><ArticleId IdType="pubmed">15689357</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka, Chopra H, Choudhary OP. mRNA vaccines as an armor to combat the infectious diseases. Travel Med Infect Dis 2023;52:102550.</Citation><ArticleIdList><ArticleId IdType="pubmed">36754340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>